Skip to main content
. 2016 Jun 28;13(7):635. doi: 10.3390/ijerph13070635

Table 7.

Analysis for smoking status difference (non-smoking and smoking) in LOX G473A genotype frequency distribution.

Genotypes Genotype Frequencies (%) p OR (95%CI)
Cancer Groups Control Groups
A. Lung Cancer 200 (100.00) 352 (100.00)
Non-smoking 118 (59.00) 256 (72.73)
GG 75 (37.50) 156 (44.30) - 1.00 (Ref.)
GA 26 (13.00) 90 (25.60) 0.08 0.62 (0.37–1.05)
AA 17 (8.50) 10 (2.84) <0.01 3.97 (1.70–9.29) *
Smoking 82 (41.00) 96 (27.27)
GG 43 (21.50) 57 (16.19) - 1.00 (Ref.)
GA 22 (11.00) 33 (9.38) 0.67 0.86 (0.43–1.73)
AA 17 (8.50) 6 (1.70) 0.03 3.25 (1.15–9.16) *
B. Colorectal Cancer 335 (100.00) 352 (100.00)
Non-smoking 262 (78.21) 256 (72.73)
GG 136 (40.60) 156 (44.30) - 1.00 (Ref.)
GA 98 (29.25) 90 (25.60) 0.23 1.25 (0.87–1.81)
AA 28 (8.36) 10 (2.84) <0.01 1.77 (1.21–2.59) *
Smoking 73 (21.79) 96 (27.27)
GG 34 (10.15) 57 (16.19) - 1.00 (Ref.)
GA 32 (9.55) 33 (9.38) 0.14 1.67 (0.85–3.27)
AA 7 (2.09) 6 (1.70) 0.41 1.30 (0.70–2.43)
C. Colon Cancer 130 (100.00) 352 (100.00)
Non-smoking 100 (76.920 256 (72.73)
GG 54 (41.54) 156 (44.30) - 1.00 (Ref.)
GA 38 (29.23) 90 (25.60) 0.38 1.25 (0.76–2.05)
AA 8 (6.15) 10 (2.84) 0.10 1.51 (0.92–2.48)
Smoking 30 (23.08) 96 (27.27)
GG 9 (6.92) 57 (16.19) - 1.00 (Ref.)
GA 16 (12.31) 33 (9.38) 0.07 2.33 (0.94–5.75)
AA 5 (3.85) 6 (1.70) 0.04 2.11 (1.02–4.38) *
D. Rectum Cancer 205 (100.00) 352 (100.00)
Non-smoking 162 (79.02) 256 (72.73)
GG 82 (40.00) 156 (44.30) - 1.00 (Ref.)
GA 60 (29.26) 90 (25.60) 0.26 1.28 (0.84–1.96)
AA 20 (9.76) 10 (2.84) <0.01 1.86 (1.24–2.80) *
Smoking 43 (20.98) 96 (27.27)
GG 25 (12.20) 57 (16.19) - 1.00 (Ref.)
GA 16 (7.81) 33 (9.38) 0.71 1.16 (0.53–2.55)
AA 2 (0.98) 6 (1.70) 0.71 0.84 (0.34–2.09)

Analysis for smoking status difference in LOX G473A genotypes performed by the unconditional logistic regression test; p values adjusted for age and sex; OR, odd ratio; CI, confidence interval. Ref., using GG as reference 1; * indicates significance statistically.